Financials Selvita S.A.

Equities

SLV

PLSLVCR00029

Biotechnology & Medical Research

Market Closed - Warsaw S.E. 11:55:45 2024-04-26 am EDT 5-day change 1st Jan Change
67 PLN -1.47% Intraday chart for Selvita S.A. -4.42% +14.53%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 375.3 904.9 1,505 1,522 1,074 1,230 - -
Enterprise Value (EV) 1 375.3 843 1,588 1,659 1,074 1,418 1,463 1,634
P/E ratio 28 x 47 x 101 x 48.8 x 15.4 x 17.6 x 28.5 x 18 x
Yield - - - - - - - -
Capitalization / Revenue 3.57 x 6.35 x 4.77 x 3.66 x 3.05 x 3.13 x 2.43 x 2.08 x
EV / Revenue 3.57 x 5.92 x 5.03 x 3.99 x 3.05 x 3.61 x 2.9 x 2.76 x
EV / EBITDA - 25.5 x 18.7 x 14.8 x 14.6 x 15.7 x 11.9 x 10.7 x
EV / FCF - 58.7 x 26.5 x 177 x - -74.6 x -24.4 x -61.9 x
FCF Yield - 1.7% 3.77% 0.57% - -1.34% -4.09% -1.62%
Price to Book - 5.75 x 7.65 x 5.8 x - 4.16 x 3.63 x 2.9 x
Nbr of stocks (in thousands) 15,971 18,355 18,355 18,355 18,355 18,355 - -
Reference price 2 23.50 49.30 82.00 82.90 58.50 67.00 67.00 67.00
Announcement Date 3/26/20 3/30/21 3/31/22 3/30/23 3/27/24 - - -
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 105.2 142.5 315.7 415.8 351.9 392.8 505.3 591.8
EBITDA 1 - 33.1 85.04 112.4 73.71 90.23 123 152.4
EBIT 1 - 19.57 57.55 44.78 16.75 34.8 67.28 88.3
Operating Margin - 13.74% 18.23% 10.77% 4.76% 8.86% 13.31% 14.92%
Earnings before Tax (EBT) 1 - 18.85 21.07 40.21 67.2 22.8 52.9 84.5
Net income 1 - 18 14.9 30.31 69.88 18.4 43.1 68.4
Net margin - 12.63% 4.72% 7.29% 19.86% 4.68% 8.53% 11.56%
EPS 2 0.8400 1.050 0.8120 1.700 3.800 3.800 2.350 3.730
Free Cash Flow 1 - 14.35 59.95 9.376 - -19 -59.9 -26.4
FCF margin - 10.07% 18.99% 2.25% - -4.84% -11.85% -4.46%
FCF Conversion (EBITDA) - 43.37% 70.49% 8.34% - - - -
FCF Conversion (Net income) - 79.75% 402.34% 30.93% - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/26/20 3/30/21 3/31/22 3/30/23 3/27/24 - - -
1PLN in Million2PLN
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 81.55 93.01 95.02 103.4 109.1 108.3 91.81 89.14 84.18 86.84 83.3
EBITDA 1 22.75 27.1 16.71 28.56 29.74 26.46 19.1 21.22 16.96 16.43 15.65
EBIT 1 5.127 - 7.858 7.65 14.73 14.53 4.275 5.386 3.317 3.768 4.9
Operating Margin 6.29% - 8.27% 7.4% 13.51% 13.42% 4.66% 6.04% 3.94% 4.34% 5.88%
Earnings before Tax (EBT) - - - - - - - - - - -
Net income 1 -2.32 8.147 4.894 - 8.993 12.7 2.447 7.875 -4.272 63.83 3.7
Net margin -2.84% 8.76% 5.15% - 8.25% 11.73% 2.67% 8.83% -5.07% 73.5% 4.44%
EPS - - - - - - - - - - -
Dividend per Share - - - - - - - - - - -
Announcement Date 11/24/21 3/31/22 5/31/22 9/16/22 11/9/22 3/30/23 5/30/23 9/27/23 11/15/23 3/27/24 -
1PLN in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 82.8 138 - 188 233 404
Net Cash position 1 - 61.9 - - - - - -
Leverage (Debt/EBITDA) - - 0.9738 x 1.225 x - 2.088 x 1.898 x 2.65 x
Free Cash Flow 1 - 14.4 59.9 9.38 - -19 -59.9 -26.4
ROE (net income / shareholders' equity) - 19.1% 24.5% 13.2% - 5% 12.2% 13.4%
ROA (Net income/ Total Assets) - 11.6% 12.3% - - - - -
Assets 1 - 154.8 121.2 - - - - -
Book Value Per Share 2 - 8.570 10.70 14.30 - 16.10 18.40 23.10
Cash Flow per Share - - - - - - - -
Capex 1 - 15 27.5 79.8 - 43.2 50.2 97.4
Capex / Sales - 10.53% 8.72% 19.19% - 10.98% 9.93% 16.46%
Announcement Date 3/26/20 3/30/21 3/31/22 3/30/23 3/27/24 - - -
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
67 PLN
Average target price
71.28 PLN
Spread / Average Target
+6.39%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SLV Stock
  4. Financials Selvita S.A.